Nah, no collateral damage at all, patent-wise.
Here's a crazy company that's been around forever, however. 385M shares out........... this "thing" has always been a bit fring(soft "g")ie, and I've never looked at their patents...........
Thursday October 18, 12:02 pm Eastern Time
Press Release
SOURCE: Advanced Viral Research Corp.
Composition Patent To Treat Viral Infections Issued
And Assigned To Advanced Viral Research Corp.
YONKERS, N.Y.--(BUSINESS WIRE)--Oct. 18, 2001--Advanced Viral Research
Corp.(OTCBB:ADVR - news) today announced the award of U.S. Patent NO. 6303153
entitled ``Preparation of a Therapeutic Composition.''
This issued patent protects the preparation and composition of Product R, the non-toxic
peptide-nucleic acid immunomodulator developed by Advanced Viral Research Corp.
Advanced Viral Research Corp. is pleased that its shareholders interests have been protected
by the grant of this patent. Patents provide shielding for the Company's intellectual property
and also facilitate introduction to potential marketing partners. The Company's scientific team,
led by Dr. Shalom Z. Hirschman, President and CEO, defined the complex chemistry of
Product R and described its effects on the immune system. The manufacturing process was
developed by Dr. Bernard Friedland, Chairman of the Board. ``This patent provides a
foundation for the continued enhancement of the protective cover for the important intellectual
property represented by Product R,'' stated Dr. Hirschman.
Product R is a non-toxic peptide nucleic acid-type immunomodulator that appears to
stimulate the proinflammatory responses required to combat viral infections such as AIDS and
human papilloma virus and to dampen aberrant autoimmune-type inflammatory responses,
such as occur in patients with rheumatoid arthritis. Therefore, Product R has been termed a
``switch type'' immunomodulator. Product R has direct antiviral effects against select viruses
such as adenovirus and human papilloma virus. Product R has shown promise in its ability to
mitigate the toxic side effects of other drugs, including those used to treat HIV infection and
chemotherapeutic drugs employed in the treatment of cancers. (snip) |
